Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Torasemide 10mg Tablets
NCT04921566Phase 1Completed
- Sponsor
- Pharmtechnology
- Start
- Jun 2021
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of torasemide in edema and hypertension (HTN) (2 arms), sponsored by Pharmtechnology. Primary endpoints: Maximum Plasma Concentration and Area Under the Concentration-Time Curve from time zero to last quantifiable concentration. Started Jun 2021; status: completed.
02
Drugs
torasemide
03
Conditions
edemahypertension (HTN)
Beyond the preview
Go deeper on NCT04921566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04921566.